{"transactions":[{"id":1658958,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-06T01:48:40.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":30906,"price":1.37,"value":42341.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2022 and February 1, 2023 pursuant to a \"sell to cover\" provision included in each RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.36 to $1.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":531615,"source":{"system":"sec-edgar","filing":"0000950170-24-011494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024011494/ownership.xml","form_type":"4"}},{"id":1658957,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-06T01:48:40.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":239731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":562521,"source":{"system":"sec-edgar","filing":"0000950170-24-011494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024011494/ownership.xml","form_type":"4"}},{"id":1793063,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-08-30T20:22:54.000Z","date":"2023-08-28","kind":"sale","planned":false,"acquired":false,"shares":1854,"price":1.26,"value":2336.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")\n that were granted to the Reporting Person on August 26, 2021 pursuant to a \"sell to cover\" provision included in the RSU Agreement."}],"balance_after":322790,"source":{"system":"sec-edgar","filing":"0000950170-23-045448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017023045448/ownership.xml","form_type":"4"}},{"id":2033065,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-02-04T00:43:02.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":3394,"price":1.86,"value":6312.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2022 pursuant to a \"sell to cover\" provision included in the RSU Agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 312,518 RSUs held by the Reporting Person."}],"balance_after":324644,"source":{"system":"sec-edgar","filing":"0000899243-23-003946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924323003946/doc4.xml","form_type":"4"}},{"id":2033064,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-02-04T00:43:02.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":265957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 312,518 RSUs held by the Reporting Person."}],"balance_after":328038,"source":{"system":"sec-edgar","filing":"0000899243-23-003946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924323003946/doc4.xml","form_type":"4"}},{"id":2414049,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T21:17:12.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":53190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":53190,"derivative":{"exercise_price":11.18,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":53190},"source":{"system":"sec-edgar","filing":"0000899243-22-004586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322004586/doc4.xml","form_type":"4"}},{"id":2414048,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:17:12.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":38014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 62,081 RSUs held by the Reporting Person."}],"balance_after":62081,"source":{"system":"sec-edgar","filing":"0000899243-22-004586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322004586/doc4.xml","form_type":"4"}},{"id":2586624,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2021-08-30T20:15:23.000Z","date":"2021-08-26","kind":"grant","acquired":true,"shares":24067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 26, 2022, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":24067,"source":{"system":"sec-edgar","filing":"0000899243-21-034500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924321034500/doc4.xml","form_type":"4"}},{"id":2960937,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-02T23:05:32.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on December 2, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting dates."}],"balance_after":75000,"derivative":{"exercise_price":17.28,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-20-032557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924320032557/doc4.xml","form_type":"4"}},{"id":3133620,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and  Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-27T21:39:34.000Z","date":"2020-05-25","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the\nremaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date."}],"balance_after":80000,"derivative":{"exercise_price":2,"expiration_date":"2030-05-24","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-20-032487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433991/000120919120032487/doc4.xml","form_type":"4"}},{"id":3291404,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and  Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-04T16:31:14.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":56250,"derivative":{"exercise_price":7.94,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001209191-20-006361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433991/000120919120006361/doc4.xml","form_type":"4"}},{"id":3433208,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and  Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-08-20T20:39:41.000Z","date":"2019-08-19","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option shall vest on August 19, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":130000,"derivative":{"exercise_price":7.27,"expiration_date":"2029-08-18","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-19-046918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433991/000120919119046918/doc4.xml","form_type":"4"}},{"id":4485289,"issuer":{"id":94539,"kind":"organization","name":"INVIVO THERAPEUTICS HOLDINGS CORP.","symbol":"NVIV"},"owners":[{"id":94613,"kind":"person","name":"JOSEPH TAMARA L","position":1,"cik":"0001433991","reported_name":"JOSEPH TAMARA L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-20T14:05:14.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments."}],"balance_after":120000,"derivative":{"exercise_price":4.35,"expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001179110-17-001105","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433991/000117911017001105/edgar.xml","form_type":"4"}}]}